Juha  Veijola

Juha Veijola


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2003 in Nordic Journal of Psychiatry
Verified
Journal Article
Closed access
JVJuha Veijola
Juha Veijola
JJJari Jokelainen
Jari Jokelainen
KLKristian Läksy
Kristian Läksy
LKLiisa Kantojärvi
Liisa Kantojärvi
PKPirkko Kokkonen
Pirkko Kokkonen
MJMatti Joukamaa
Matti Joukamaa
Simple screening questionnaires for major psychiatric disorders are needed for epidemiological research and clinical work. We describe the characteristics of the Hopkins Symptom Checklist-25 (HSCL-25) as a screening instrument in a two-phase epidemiological survey using the Structured Clinical Interview for DSM-III-R (SCID) as a diagnostic tool. The material consisted of 1609 subjects aged 31 years who were asked to participate in a health survey. The invitation included the HSCL-25 questionnaire. All "screen-positive" (HSCL-25 mean>/=1.55) subjects and every tenth "screen-negative" subject were invited to participate in the SCID interview. The sensitivity of the HSCL-25 for any present DSM-III-R axis-I psychiatric disorder was 48%. The specificity was 87%. The sensitivity of cases with comorbid psychiatric disorders was 100%. The HSCL-25 is a moderate instrument for screening with present axis-I DSM-III-R psychiatric disorders in a young adult population. It can be recommended for screening of psychiatric disorders.

1 July 2019 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
PWPetri Wiklund
Petri Wiklund
VKVille Karhunen
Ville Karhunen
RRRebecca C. Richmond
Rebecca C. Richmond
PPPriyanka Parmar
Priyanka Parmar
Alina RodriguezAlina Rodriguez
Alina Rodriguez
MJMarjo-Riitta Järvelin
Marjo-Riitta Järvelin
Maternal smoking during pregnancy is associated with adverse offspring health outcomes across their life course. We hypothesize that DNA methylation is a potential mediator of this relationship. We examined the association of prenatal maternal smoking with offspring blood DNA methylation in 2821 individuals (age 16 to 48 years) from five prospective birth cohort studies and perform Mendelian randomization and mediation analyses to assess whether methylation markers have causal effects on disease outcomes in the offspring. We identify 69 differentially methylated CpGs in 36 genomic regions (P value < 1 × 10−7) associated with exposure to maternal smoking in adolescents and adults. Mendelian randomization analyses provided evidence for a causal role of four maternal smoking-related CpG sites on an increased risk of inflammatory bowel disease or schizophrenia. Further mediation analyses showed some evidence of cg25189904 in GNG12 gene mediating the effect of exposure to maternal smoking on schizophrenia-related outcomes. DNA methylation may represent a biological mechanism through which maternal smoking is associated with increased risk of psychiatric morbidity in the exposed offspring.

18 July 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JVJuha Veijola
Juha Veijola
JGJoyce Y Guo
Joyce Y Guo
JMJani S Moilanen
Jani S Moilanen
EJErika Jääskeläinen
Erika Jääskeläinen
Jouko MiettunenJouko Miettunen
Jouko Miettunen
GMGraham K Murray
Graham K Murray
Studies show evidence of longitudinal brain volume decreases in schizophrenia. We studied brain volume changes and their relation to symptom severity, level of function, cognition, and antipsychotic medication in participants with schizophrenia and control participants from a general population based birth cohort sample in a relatively long follow-up period of almost a decade. All members of the Northern Finland Birth Cohort 1966 with any psychotic disorder and a random sample not having psychosis were invited for a MRI brain scan, and clinical and cognitive assessment during 1999–2001 at the age of 33–35 years. A follow-up was conducted 9 years later during 2008–2010. Brain scans at both time points were obtained from 33 participants with schizophrenia and 71 control participants. Regression models were used to examine whether brain volume changes predicted clinical and cognitive changes over time, and whether antipsychotic medication predicted brain volume changes. The mean annual whole brain volume reduction was 0.69% in schizophrenia, and 0.49% in controls (p = 0.003, adjusted for gender, educational level, alcohol use and weight gain). The brain volume reduction in schizophrenia patients was found especially in the temporal lobe and periventricular area. Symptom severity, functioning level, and decline in cognition were not associated with brain volume reduction in schizophrenia. The amount of antipsychotic medication (dose years of equivalent to 100 mg daily chlorpromazine) over the follow-up period predicted brain volume loss (p = 0.003 adjusted for symptom level, alcohol use and weight gain). In this population based sample, brain volume reduction continues in schizophrenia patients after the onset of illness, and antipsychotic medications may contribute to these reductions.

1 April 2011 in Journal of Nervous & Mental Disease
Verified
Journal Article
Closed access
Jouko MiettunenJouko Miettunen
Jouko Miettunen
JVJuha Veijola
Juha Veijola
MIMatti Isohanni
Matti Isohanni
TPTiina Paunio
Tiina Paunio
NFNelson Freimer
Nelson Freimer
DLDirk Lichtermann
Dirk Lichtermann
We study the predictive power and associations of several psychopathology and temperament scales with respect to schizophrenia and other psychotic disorders. Measures of psychopathology (Physical and Social Anhedonia Scales, Perceptual Aberration Scale, Hypomanic Personality Scale, Bipolar II Scale, and Schizoidia Scale) and the Temperament and Character Inventory were included in the 31-year follow-up of the prospective Northern Finland 1966 birth cohort (N = 4926). The Perceptual Aberration Scale was the best scale for concurrent validity in psychoses, and also the best psychopathology scale in terms of discriminant validity. Participants scoring high in hypomanic personality were at the highest risk for developing psychosis during the 11-year follow-up. Harm avoidance was a dominant temperament dimension in individuals with psychosis compared with participants without psychiatric diagnoses. These scales are useful as vulnerability markers in studying psychoses.

5 June 2012 in Early Intervention in Psychiatry
Verified
Journal Article
Closed access
PDF file
JVJuha Veijola
Juha Veijola
PMPirjo Mäki
Pirjo Mäki
EJErika Jääskeläinen
Erika Jääskeläinen
JKJenni Koivukangas
Jenni Koivukangas
IMIrma Moilanen
Irma Moilanen
Jouko MiettunenJouko Miettunen
Jouko Miettunen

1 July 2007 in Social Science & Medicine
Verified
Journal Article
Closed access
MEMarko Elovainio
Marko Elovainio
MKMika Kivimaki
Mika Kivimaki
EEEllen Ek
Ellen Ek
JVJussi Vahtera
Jussi Vahtera
THTeija Honkonen
Teija Honkonen
MJMarjo-Riitta Järvelin
Marjo-Riitta Järvelin